SCHEMBL8641978

SCHEMBL8641978

CC(O)c1ccc(-c2c(C#N)n[nH]c2-c2ccc([S+](C)[O-])cc2)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERBB2 P04626 1/20 0.35
PGR P06401 1/20 0.34
RPS6KA3 P51812 2/20 0.30
EEF2K O00418 1/20 0.30
PLK4 O00444 1/20 0.30
DAPK3 O43293 1/20 0.30
DYRK3 O43781 1/20 0.30
ROCK2 O75116 1/20 0.30
PRKD3 O94806 1/20 0.30
MAP4K4 O95819 1/20 0.30
NTRK1 P04629 1/20 0.30
CDK1 P06493 1/20 0.30
RET P07949 1/20 0.30
FGFR1 P11362 1/20 0.30
FER P16591 1/20 0.30
FLT1 P17948 1/20 0.30
RPS6KB1 P23443 1/20 0.30
CDK2 P24941 1/20 0.30
MARK3 P27448 1/20 0.30
FLT4 P35916 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8640165 0.83 RPS6KA3 (0.33) RPS6KA3EEF2KPLK4DAPK3DYRK3
SCHEMBL8641982 0.81 ERBB2 (0.36) ERBB2PGRRPS6KA3EEF2KPLK4
SCHEMBL8196133 0.73 GRM5 (0.41) DYRK1A
SCHEMBL16667384 0.71 NOS3 (0.39) PGR
SCHEMBL8637992 0.64 MAPK14 (0.46) RPS6KA3
SCHEMBL8200029 0.63 XDH (0.39) RPS6KA3MAP4K4RETKDRGSK3B
SCHEMBL9274671 0.62 KMT2A (0.39) CDK2DYRK1A
SCHEMBL8196073 0.62 ENPP1 (0.35) RPS6KA3
SCHEMBL8201683 0.62 MAPK14 (0.44) RPS6KA3
SCHEMBL8642614 0.61 PTGS2 (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0856000-A1 1,3,5-TRISUBSTITUTED PYRAZOLES FOR TREAMENT OF INFLAMMATION FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-08-05 EP disclosed
WO-1997013755-A1 1,3,5-TRISUBSTITUTED PYRAZOLES FOR TREAMENT OF INFLAMMATION FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-04-17 WO disclosed